- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.79 BnMarket Estimate, 2026
$1.89 BnMarket Forecast, 2034
$2.89 BnCAGR, 2026–2034
5.46%North America Orthobiologics Market Size, Trends, and Forecast (2026-2034)
- Market Scope: Comprehensive regional industry analysis covering products (viscosupplementation, DBM, synthetic orthobiologics, BMP, allografts, PRP, and BMAC), applications (osteoarthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial/dental), end-users, and country-level adoption across the United States, Canada, Mexico, and the wider North American region.
- Market Valuation: Valued at USD 1.79 billion in 2025, estimated at USD 1.89 billion in 2026, and projected to reach USD 2.89 billion by 2034, registering a compound annual growth rate (CAGR) of 5.46% from 2026 to 2034.
- Primary Growth Drivers: Rapidly expanding geriatric demographic, high prevalence of osteoarthritis and sports injuries, shift from traditional mechanical implants to advanced biological alternatives, and growing adoption of minimally invasive surgeries.
Key Market Segment Metrics (2026-2034)
| Category | Leading Segment (Base Position) | Fastest-Growing / Promising Segment |
|---|---|---|
| By Product & Application | Viscosupplementation & Allografts (dominant baseline demand for joint therapies and bone grafting) & Osteoarthritis/Degenerative Arthritis | Platelet-Rich Plasma (PRP) & Bone Marrow Aspirate Concentrate (BMAC) (expanding via regenerative cellular medicine) & Spinal Fusion |
| By Country | United States (largest global and regional market share driven by advanced healthcare infrastructure and high product awareness) | Canada (projecting a strong 8.3% CAGR supported by increasing research investments, rising bone-healing awareness, and aging populations) |
Major Market Players & Industry Structure
Market Structure: Highly competitive environment led by major medical technology corporations focusing on biologic innovations, expanded clinical indications, and robust regional distribution networks.
Key Industry Companies: Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, and Kuros Biosciences.
Download Free Sample Report
North America Orthobiologics Market Size
The North America orthobiologics market was valued at USD 1.79 billion in 2025. The market is estimated at USD 1.89 billion in 2026 and is projected to reach USD 2.89 billion by 2034, growing at a CAGR of 5.46% from 2026 to 2034.
MARKET DRIVERS
Rising Geriatric Population and Sports Injuries Fuel Orthobiologics Demand
The Orthobiologics market in North America is majorly driven by the growing aging population suffering from osteoarthritis. This disease is the most common joint disorder in North America and affects 10% of men and 13% of women aged above 60. Technological advancements by the major companies operating in the market are further accelerating the Orthobiologics market in North America.
Adopting a sedentary lifestyle and changes in food habits leads to the increasing number of orthopedic-related diseases that escalate the demand of the North American orthobiologics market. Creating awareness over the benefits associated with orthobiologics is leveling up the growth rate of the market. Orthopedic surgeons use these orthobiologics as drugs to speed up the recovery time. The usage of these drugs is going higher in the US, promoting the demand of the market in North America. Orthopedic problems are more common among the geriatric population, where increasing older people in North America are ascribed to bolster the market's demand.
Additionally, the growing occurrence rate of sports injuries, road accidents, and the rising adoption of minimally invasive surgeries are also swelling the market's growth rate. Health problems such as over-weight and improving economic conditions are estimated to support the market in North America.
MARKET RESTRAINTS
High Costs and Regulatory Barriers Restrain Orthobiologics Market Growth
High costs associated with and strict regulations for the devices and products' approval procedure restrict the market growth to a small extent. Lack of reimbursement policies, lack of awareness among people who live in rural areas, and shortage of professional orthopedics during surgery and treatment are likely to obstruct the North American Orthobiologics market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product, Application, End Users, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | United States, Canada, Mexico, Rest of North America |
| Market Leaders Profiled | Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, among others. |
COUNTRY LEVEL ANALYSIS
Regionally, North America has the largest market for orthobiologics in the world by share. In the North American region, the United States has the largest share. Factors such as the growing incidence of musculoskeletal and orthopedic diseases and rising government support are expected to drive the region's market growth.
The U.S. Orthobiologics market had accounted for the largest market share in the North American market in 2022. The growing awareness actively drives the United States market in people regarding the advantages of orthobiologics and their changing importance from mechanical implants to biological implants. Advancements in technology, growing funds, and investments towards the market and few players are expected to enter the forthcoming years.
The Canadian Orthobiologics market is expected to hike at a CAGR of 8.3% due to increasing awareness in people about the advantages like faster bone healing, decreased number of hospital visits, and quick recovery in this region. Moreover, the growth in this country is also driven by growing investments related to research, which helps develop this region. Furthermore, increasing orthopedic diseases incorporated with an increasingly aging population foster the orthobiologics market in this region.
KEY MARKET PLAYERS
Major companies leading the North American Orthobiologics Market profiled in this report are Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, among others.
MARKET SEGMENTATION
This research report on the North America Orthobiologics Market has been segmented & sub-segmented into the following categories:
By Product
- Viscosupplementation
- Demineralized Bone Matrices
- Synthetic Orthobiologics
- Bone Morphogenic Protein
- Allografts
- Plasma-Rich Protein
- Bone Marrow Aspirate Concentrate
By Application
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial & Dental Applications
By End Users
- Hospitals
- Orthopedic Clinics
- Ambulatory Care Centres
- Research and Academic Institutes
- Dental Clinics & Facilities
By Country
- The United States
- Canada
- Rest of North America